Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort

Steven F. G. Jeuring*, Vince B. C. Biemans, Tim R. A. van den Heuvel, Maurice P. Zeegers, Wim H. Hameeteman, Marielle J. L. Romberg-Camps, Liekele E. Oostenbrug, Ad A. M. Masclee, Daisy M. A. E. Jonkers, Marieke J. Pierik

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)384-395
Number of pages12
JournalAmerican Journal of Gastroenterology
Volume113
Issue number3
DOIs
Publication statusPublished - Mar 2018

Keywords

  • CROHNS-DISEASE
  • ULCERATIVE-COLITIS
  • NATURAL-HISTORY
  • INCEPTION COHORT
  • CONTROLLED-TRIAL
  • 5-AMINOSALICYLIC ACID
  • MEDICAL-MANAGEMENT
  • CLINICAL-COURSE
  • FOLLOW-UP
  • AZATHIOPRINE

Cite this